FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10304011000001103: PEP tablets (Galpharm International Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
35517501000001111 PEP tablets (Galpharm International Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
35517601000001110 PEP tablets (Galpharm International Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
PEP tablets (Galpharm International Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Is a Glucose 150mg / Caffeine 30mg tablets true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Has active ingredient Caffeine true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Has active ingredient Glucose monohydrate false Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Is a PEP - brand name true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Has specific active ingredient Glucose monohydrate false Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Has specific active ingredient Caffeine true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Has active ingredient Glucose true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) Has specific active ingredient Glucose monohydrate true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
PEP tablets (Galpharm International Ltd) 20 tablet Is pack of False PEP tablets (Galpharm International Ltd) Inferred relationship Existential restriction modifier
PEP tablets (Galpharm International Ltd) 20 tablet Has AMP True PEP tablets (Galpharm International Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start